Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database

Yuanyuan Li1, Wenqiang Li1, Baocai Xu2

  • 1Department of ICU, Jining No.1 People's Hospital, Jining, China.

PubMed
Abstract

Insights

Mean blood glucose levels in critically ill patients show a J-shaped association with mortality. Higher glucose levels increase the risk of death, particularly in patients without diabetes, hypoglycemia, or liver disease.

Area of Science:

  • Critical care medicine
  • Endocrinology
  • Clinical epidemiology

Background:

  • Mean blood glucose (MBG) is a significant predictor of mortality in critically ill patients.
  • Understanding the precise relationship between MBG and mortality is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the association between mean blood glucose (MBG) and intensive care unit (ICU) mortality.
  • To explore this relationship across different patient subgroups.

Main Methods:

  • A cohort study utilizing the Medical Information Mart for Intensive Care IV (MIMIC-IV) database.
  • Calculation of MBG to represent overall glycemic status during ICU hospitalization.
  • Multivariate logistic regression and restricted cubic spline analyses to determine the MBG-mortality relationship.

Main Results:

  • A total of 8,973 patients were analyzed, with 1,244 deaths within 28 days.
  • A J-shaped relationship was observed between MBG and ICU mortality.
  • Hyperglycemia (glucose ≥10 mmol/L) was associated with increased mortality (adjusted OR 2.06).
  • The impact of hyperglycemia on mortality was more pronounced in patients without diabetes, hypoglycemia, or liver disease.

Conclusions:

  • A J-shaped relationship exists between MBG and mortality in critically ill patients.
  • Hyperglycemia poses a significant mortality risk, especially in specific patient subgroups.

Related Concept Videos

SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...